Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 643
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07325292 Frexcite — Non-inferiority Study of Frexalimab Subcutaneous Administrat… |
Frexalimab | SEP | Phase 3 | RECRUITING | En attente / non publié | Sanofi | United States, Belgium, China, Italy, Japan · Advance… | 2026-01-14 → 2028-11-30 | Ouvrir |
| NCT03437473 Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumato… |
SetPoint Medical Neurostimulation… | SEP | Non applicable | COMPLETED | En attente / non publié | SetPoint Medical Corporation | United States · Altoona Center for Clinical Research,… | 2018-03-06 → 2018-12-10 | Ouvrir |
| NCT07489326 ACTIVATE — The SetPoint System Safety & Performance Post-Approval Study |
SetPoint System | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | SetPoint Medical Corporation | Non communiqué | 2026-04-15 → 2031-01-01 | Ouvrir |
| NCT04862117 Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in… |
SetPoint Medical Neurostimulation… | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | SetPoint Medical Corporation | United States · Altoona Center for Clinical Research,… | 2018-07-28 → 2026-12-08 | Ouvrir |
| NCT04539964 RESET-RA — Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Ar… |
Implant Procedure | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | SetPoint Medical Corporation | United States · Albuquerque Center For Rheumatology, … | 2021-01-11 → 2027-10 | Ouvrir |
| NCT07337785 CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Dis… |
CD19/BCMA-targeted CAR-T cells | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital, Tongji Medical College, Huaz… | 2025-12-12 → 2028-11-01 | Ouvrir |
| NCT07753122 ME/CFS — Controlled Trial of Hydrogen Water as a Treatment for Myalgic … |
ME/CFS — Controlled Trial of Hydr… | Myopathies | Non applicable | RECRUITING | En attente / non publié | Fred Friedberg | United States · Stony Brook University, Stony Brook, … | 2026-08-15 → 2027-07 | Ouvrir |
| NCT06995898 The Vanguard Study: Testing a New Way to Screen for Cancer |
Biospecimen Collection | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Cancer Care and Hematology-Fort Colli… | 2025-06-18 → 2029-06-30 | Ouvrir |
| NCT03455582 PRO-COG — Cognition Evolution and MRI Markers in PPMS Patients on 2 Yea… |
MRI Evaluation | SEP | Non applicable | COMPLETED | En attente / non publié | University Hospital, Bordeaux | France · CHU de Bordeaux, Bordeaux, France | CHU de L… | 2018-09-24 → 2026-04-15 | Ouvrir |
| NCT07115017 FZTA Pilot — This Study Involves a Positron Emission Tomography (PET) S… |
[18F] FZTA | SEP | À vérifier | RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University in St. Louis, S… | 2025-08-22 → 2029-12 | Ouvrir |
| NCT03368664 LemKids — A Study to Evaluate Efficacy, Safety, and Tolerability of Ale… |
Alemtuzumab GZ402673 | SEP | Phase 3 | TERMINATED | En attente / non publié | Genzyme, a Sanofi Company | France, Italy, Poland, Russia, Turkey (Türkiye), Unit… | 2017-10-23 → 2025-09-08 | Ouvrir |
| NCT02511028 In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmal… |
Ferumoxytol | SEP | Phase 1 | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2015-11-27 → 2019-01-29 | Ouvrir |
| NCT04121221 A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acti… |
GA Depot | SEP | Phase 3 | COMPLETED | En attente / non publié | Mapi Pharma Ltd. | United States, Belarus, Bosnia and Herzegovina, Bulga… | 2019-09-19 → 2023-06-13 | Ouvrir |
| NCT06197685 COMBINE — A Novel Combinatory Approach to Maximize Functional Recovery … |
COMBINE — A Novel Combinatory App… | SEP | Non applicable | RECRUITING | En attente / non publié | Kessler Foundation | United States · Kessler Foundation, East Hanover, Uni… | 2024-02-12 → 2027-09-30 | Ouvrir |
| NCT07390201 Effect of Sensory Integration Therapy on Gait Variability and Quality O… |
Effect of Sensory Integration The… | SEP | Non applicable | COMPLETED | En attente / non publié | Cairo University | Egypt · Kasr Al Ainy Multiple Sclerosis Clinic, Giza,… | 2026-02-05 → 2026-07-20 | Ouvrir |
| NCT07587125 RESET-MS — Safety and Efficacy of S103 Cells in Progressive/Refractory … |
S103 cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Xijing Hospital | China · Xijing Hospital, Xi'an, China | 2026-05-08 → 2029-11 | Ouvrir |
| NCT06401928 Electrical Brain Stimulation for Treatment of Secondary Symptoms in Mul… |
Transcranial Direct Current stimu… | SEP | Non applicable | COMPLETED | En attente / non publié | Dr. Ram Manohar Lohia Hospital | Iran · Multiple Sclerosis Association of Guilan, Rash… | 2023-02-28 → 2024-01-31 | Ouvrir |
| NCT01392872 CoQualSEP — Cognitive Disability and Quality of Life of Patients Suffer… |
CoQualSEP — Cognitive Disability … | SEP | Non applicable | COMPLETED | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU Clermont-Ferrand, Clermont-Ferrand, Fran… | 2009-11 → 2016-01 | Ouvrir |
| NCT07606742 VAMOS-MS — Delivery of a Culturally Tailored Exercise Training Interven… |
VAMOS-MS — Delivery of a Cultural… | SEP | Non applicable | RECRUITING | En attente / non publié | The University of Texas Health Sc… | United States · The University of Texas Health Scienc… | 2026-09-01 → 2028-10-31 | Ouvrir |
| NCT07749690 Mental Rotation and Motor Imagery Training in Multiple Sclerosis |
Mental Rotation and Motor Imagery… | SEP | Non applicable | COMPLETED | En attente / non publié | Abant Izzet Baysal University | Turkey (Türkiye) · Abant Izzet Baysal University Facu… | 2024-02-15 → 2026-02-15 | Ouvrir |
| NCT05755061 WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multip… |
WEBCAMS: Walking Exercise for Bra… | SEP | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Kessler Foundation | United States · Kessler Foundation, West Orange, Unit… | 2023-02-01 → 2027-01-31 | Ouvrir |
| NCT07074886 PORTAMENTO — A Study to Assess Bioequivalence of Two Subcutaneous (SC) … |
Ocrelizumab Test Formulation | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Brazil, France, Germany, It… | 2025-11-13 → 2030-03-31 | Ouvrir |
| NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) … |
Tofersen | Sclérose latérale amyotrophique | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biogen | China · Peking University Third Hospital, Beijing, Ch… | 2025-12-11 → 2027-05-26 | Ouvrir |
| NCT06869122 AB1MALTISC-UK — Bronchoscopic Microwave Ablation of Lung Tissue in Surg… |
Ablation | Cancer | À vérifier | RECRUITING | En attente / non publié | Western University, Canada | Italy, United Kingdom · Istituto Europeo di Oncologia… | 2025-07-14 → 2026-12 | Ouvrir |
| NCT06703216 PACER — Pre-emptive Anakinra for Cytokine Event Reduction |
Anakinra (Kineret®) | Cancer | Phase 1 | WITHDRAWN | En attente / non publié | Kevin McNerney | United States · Ann & Robert H. Lurie Children's Hosp… | 2026-10 → 2030-02-28 | Ouvrir |